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Dapsone (4,40-diaminodiphenylsulfone) has been used for a variety of dermatological conditions.
Dapsone-induced drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare but severe
drug reaction characterized by fever, cutaneous eruption, and systemic involvement. We present a case of
dapsone-induced DRESS, which resulted in fever, maculopapular eruptions progressing to exfoliative
dermatitis, cervical lymphadenopathy, transaminitis, and hypersensitivity myocarditis resulting in
congestive heart failure. This patient was withdrawn from dapsone and treated with systemic cortico-
steroids, but he ﬁnally passed away despite aggressive intensive care. We report this rare case and review
the literature concerning DRESS with cardiac involvement.
Copyright  2011, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Drug reaction with eosinophilia and systemic symptoms (DRESS) is
a rare but severe drug reaction characterized by fever, skin erup-
tion, and systemic involvement, including lymphadenopathy,
abnormal liver function, renal impairment, pulmonary or pericar-
dial inﬁltrates, and hematologic abnormalities, mainly hyper-
eosinophilia and lymphocytosis. Symptoms typically begin
between 2 weeks and 6 weeks after initiation of drug therapy and
mostly subside after discontinuing the drug.1 However, potentially
life-threatening events have been reported. The 10% mortality rate
associated with DRESS is usually secondary to hepatotoxicity or
myocarditis.2
Dapsone is the drug of choice for treatment of leprosy and
dermatitis herpetiformis and can be used for various kinds of
inﬂammatory skin diseases. Dapsone-induced DRESS with
myocarditis is a rare but potentially fatal complication. In this
article, we present a case of dapsone-induced DRESS with hyper-
sensitivity myocarditis and review previous reports of dapsone-
induced DRESS with cardiac involvement.Case report
A 33-year-old man presented with fever, malaise, multiple oral
ulcers, and generalized itchy erythematous maculopapular rashgy, Taipei Veterans General
, Taiwan.
iwanese Dermatological Associatiowith scaling on the face, trunk, and limbs for 3 weeks (Figure 1). He
had received dapsone 100 mg daily for 6 weeks because of chronic
refractory urticaria. Dapsone-related drug eruption was suspected,
and dapsone was therefore discontinued. Topical clobetasol cream
and oral prednisolone (30 mg/d) were given in another medical
setting but did not alleviate his symptoms. Then, hewas transferred
to our hospital.
On admission, his body temperature was 38.7C, blood pressure
86/52 mmHg, and heart rate 135 beats/min. Other physical exam-
inations of cardiovascular and respiratory system were unremark-
able. Bilateral cervical lymphadenopathy was palpable. His skin
biopsy showed spongiosis, necrotic keratinocytes, and a dense
perivascular inﬂammatory inﬁltrate of lymphohistiocytes and
eosinophils (Figure 2). Laboratory investigations revealed hemo-
globin, 13.9 g/dL (normal range: 14e18 g/dL); platelet count,
495,000/mL (normal range: 150,000e450,000/mL); leukocyte count,
17,700/mL (eosinophil,10%); total serum bilirubin, 0.3 mg/dL (normal
range: 0.2e1.6 mg/dL); aspartate aminotransferase, 226 U/L
(normal range: 0e40 U/L); and alanine aminotransferase, 252 U/L
(normal range: 5e45 U/L). Hepatitis B surface antigen, hepatitis C
virus antibody, anti-dsDNA, antimitochondrial antibody, anti-Jo-1
antibody, and extractable nuclear antigen were tested to rule out
viral and autoimmune hepatitis. The workup was all negative.
Subsequent laboratory studies for systemic infection, including
cytomegalovirus (CMV), Epstein-Barr virus (EBV), toxoplasma,
herpes simplex virus, and HIV, were all negative. Intravascular
hydrocortisone 150 mg daily was then given under the impression
of DRESS. However, the patient developed chest pain and dyspnea
1 week after admission. Cardiac ischemic change was detected byn. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 A 33-year-old male patient presented with generalized exfoliative dermatitis involving most of the trunk and limbs. (A) Diffuse itchy scaly erythematous-to-brownish
papulosquamous eruptions on the trunk. (B) A closer view of the patient’s back showing conﬂuent brownish papulosquamous lesions with moderate scaling.
W.-H. Li et al. / Dermatologica Sinica 29 (2011) 63e6664abnormal electrocardiogram (ST elevation in leads V1, V2, and
T-wave inversion in V3eV6) and elevated cardiac enzyme (creati-
nine kinase,1074 U/L (normal range: 40e210 U/L)). Troponin-I level
was 13.43 ng/mL (<1.5 ng/mL). The echocardiography revealed
generalized hypokinesia and markedly declined left ventricular
ejection fraction (from 64% to 11%). The patient’s coronary
angiography demonstrated patent coronary arteries. The endo-
myocardial biopsy revealed organizing endomyocarditis with
eosinophilic inﬁltration (Figure 3). His condition deteriorated
rapidly, and he passed away despite aggressive intensive care and
extracorporeal membrane oxygenation support.Figure 2 Biopsy specimens from the exfoliative lesions. (A) These specimens demonstrate
interstitial mixed inﬂammatory cell inﬁltrate composed of lymphohistiocytes and eosinophi
Dyskeratotic cells in the epidermis (H&E, original magniﬁcation 400).Discussion
Dapsone (4,40-diaminodiphenylsulfone) is the parent compound of
the sulfones. It has a history of more than a century and remains
a powerful therapeutic tool for many skin diseases, including
leprosy, dermatitis herpetiformis, erythema elevatum diutinum,3
linear immunoglobulin A dermatosis,4 and the bullous eruption
of systemic lupus erythematosus.5 It is an alternative treatment for
chronic idiopathic urticaria.6
The anti-inﬂammatory effects of dapsone are mainly associ-
ated with its interference with neutrophil chemotactic migration,spongiosis, acanthosis with dyskeratotic cells in the epidermis, and a perivascular and
ls in the upper dermis [hematoxylin and eosin (H&E), original magniﬁcation 100]. (B)
Figure 3 Endomyocardial biopsy demonstrates endocardial ﬁbrosis with inﬁltrate of
lymphohistiocytes and eosinophils (hematoxylin and eosin, original magniﬁcation
400).
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toxic respiratory/secretory products and oxidants.7 There have
been reported dapsone-induced adverse effects, including
hemolysis, agranulocytosis, methemoglobinemia, hepatobiliary
damage, and cutaneous involvement (morbilliform eruptions,
erythema multiforme, exfoliative dermatitis, or toxic epidermal
necrolysis).8
The deﬁnition of DRESS was proposed by Bocquet et al1 as fever
with eosinophilia, skin rash, and multisystemic involvement in
1996. It is a rare but serious drug reaction with delayed onset,
variable clinical presentation, and prolonged course. Various groups
of drugs are emerging as culprits of DRESS, including aromatic
anticonvulsants, antidepressants, sulfones, sulfonamides, allopu-
rinol, nonsteroidal anti-inﬂammatory drugs, anti-infective agents
(minocycline, penicillin, metronidazole, terbinaﬁne), angiotensin-
converting enzyme inhibitors, and b-blockers. Aromatic anticon-
vulsants and sulfonamides are the most common culprit drugs
inducing DRESS.9,10 The interval between ﬁrst drug exposure
and symptoms is usually 2e4 weeks but has been reported in
individuals receiving anticonvulsants for 3 months.11 Cutaneous
manifestations in DRESS can be presented as facial edema, mac-
ulopapular eruptions, or exfoliative dermatitis. Multivisceral
involvement may be manifested as lymphadenopathy, hepatitis,
cholangitis, renal toxicity, pneumonitis, myocarditis, pericardial
effusion, thyroiditis, and cerebral edema. Hematological abnor-
malities include hypereosinophilia and lymphocytosis with large,
activated, and sometimes atypical, circulating lymphocytes.12e14Table 1 Cases of dapsone-induced DRESS syndrome with cardiac involvement in the lite
Case Age/sex Race Interval (wk) Clinical presentations
1 71/M Chinese 8 Fever, jaundice, hepatomegaly, transami
failure, pleural effusion, myocarditis, and
2 22/M Malaysian 12 Fever, rash, lymphadenopathy, hypereos
serositis, hepatitis, hypersensitivity myo
and congestive heart failure
3 45/F Chinese 5 High fever, generalized maculopapular r
atrial-ventricular block, two episodes of
Our case 33/M Chinese 6 Fever, exfoliative dermatitis, lymphaden
hypersensitivity myocarditis, and congesDRESS has been associated with considerable morbidity and
mortality, which is 10% if unrecognized and untreated.2
The pathogenesis of DRESS still remains unclear, but it is likely
to involve a complex interaction of many factors, including
genetics, immunology, individual metabolic difference in the
production and detoxiﬁcation of reactive metabolites, and reac-
tivation of latent viruses of the human herpes virus (HHV) family,
including HHV-6, CMV, EBV, and HHV-7.15 Our patient had negative
serologies for CMV and EBV. HHV-6 and HHV-7 serologies were not
tested.
DRESS with myocardial involvement has been induced by
various drugs, such as antibiotics (sulfonamides and penicillins),
anticonvulsants, diuretics, allopurinol, and antipsychotic agents.16
Cardiac involvement is an unusual presentation of dapsone-
induced DRESS. To date, only three cases of DRESS with cardiac
involvement were documented at the time of this literature review
(Table 1).17e19 The total four cases, including our case, were Asians
(3 Chinese and 1 Malaysian). Including our patient, there were
three cases manifested as hypersensitivity myocarditis combined
with fever, skin rash, and transaminitis. The other one case pre-
sented as complete atrial-ventricular block and had episodes of
syncope. One case of myocarditis was diagnosed with postmortem
histological examination. Despite systemic corticosteroids treat-
ment, intensive care, and immediate withdrawal of dapsone, two of
them eventually died. Clinicians should be vigilant for the possi-
bilities of hypersensitivity myocarditis when the signs and symp-
toms of drug hypersensitivity coexist with nonspeciﬁc cardiac
ﬁndings, such as unexplained tachycardia, electrocardiographic
changes, and elevations of cardiac enzymes.20 An endomyocardial
biopsy remains the golden standard for diagnosis of myocarditis.16
Many factors, including delayed endomyocardial biopsy and inad-
equate sampling, contributed to underestimation of hypersensi-
tivity myocarditis.
DRESS must be promptly recognized and all potential culprit
drugs should be withdrawn. Although controlled clinical trials
regarding the effectiveness of corticosteroids in DRESS are lack-
ing, it is recommended for patients with life-threatening visceral
manifestations. The recommended dose of corticosteroids is
0.5e1 mg/kg/d.14 Because dapsone is found to persist in the body
for up to 35 days because of protein binding and enterohepatic
recirculation, slow tapering of corticosteroids over at least 1
month with close monitoring of organ function is required. When
the skin rash results in exfoliative dermatitis, supportive care
consists of warming the environmental temperature and using
local antiseptics and topical corticosteroids.21 If the erythroderma
is severe, clinicians should be vigilant to the development of
cardiac failure in elderly patients or those with prior cardiac
disease.
Dapsone-induced DRESS with hypersensitivity myocarditis is
a rare but potentially fatal adverse reaction. Patients treated withrature.
Management Outcomes Reference
nitis, acute renal
hypereosinophilia
Withdraw dapsone, intensive care Expired Lau17
inophilia, thyroiditis,
carditis,
Withdraw dapsone, prednisolone
40 mg/d, intensive care
Recovery Teo et al18
ash, complete
syncope
Methylprednisonlone 320 mg/d Recovery Zhu et al19
opathy, transaminitis,
tive heart failure
Withdraw dapsone, prednisolone
30 mg/d, then hydrocortisone
150 mg/d, intensive care
Expired Present
study
W.-H. Li et al. / Dermatologica Sinica 29 (2011) 63e6666dapsone for various indications are required to be monitored
carefully for the development of DRESS.References
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